PALO ALTO, Calif., Nov. 28, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced it is partnering with Penn Medicine to
The in-person training consists of up to 40 weeks of onsite training at Penn Medicine in Philadelphia. During these training sessions, participants will be able to work directly with the experts in a clinical environment. The immersive program allows for in-clinic observation and live hands-on learning. The online program will offer over 80 different training models designed and led by proton therapy experts from Penn Medicine. The modules cover all aspects of proton therapy from the basics of proton therapy, to beam commissioning and quality assurance, to extensive review of clinical topics and outcomes. For more information on this training program, visit https://www.varian.com/proton-training.
"We are proud to be partnering with Penn Medicine on this new comprehensive proton therapy training program," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division. "Continued education and training is playing an important role in the growing availability of proton therapy. Through this new program we have the ability to expand the knowledge and skills of clinicians and therapists in proton therapy around the world."
About Varian Varian focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press ContactMark PlungyVarian Medical Systems+1 (650) 424-5630 [email protected]
View original content:http://www.prnewswire.com/news-releases/varian-partners-with-penn-medicine-for-proton-therapy-training-and-education-program-300561931.html
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All